253 related articles for article (PubMed ID: 15653127)
1. Absence of nucleotide polymorphism in a Plasmodium vivax multidrug resistance gene after failure of mefloquine prophylaxis in French Guyana.
Picot S; Brega S; Gérôme P; Velut G; de Monbrison F; Cheminel V; Peyron F
Trans R Soc Trop Med Hyg; 2005 Mar; 99(3):234-7. PubMed ID: 15653127
[TBL] [Abstract][Full Text] [Related]
2. Atovaquone + proguanil: new preparation. Second-line antimalarial combination.
Prescrire Int; 2002 Oct; 11(61):131-6. PubMed ID: 12378742
[TBL] [Abstract][Full Text] [Related]
3. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
Marfurt J; Müeller I; Sie A; Maku P; Goroti M; Reeder JC; Beck HP; Genton B
Am J Trop Med Hyg; 2007 Nov; 77(5):947-54. PubMed ID: 17984359
[TBL] [Abstract][Full Text] [Related]
4. Mefloquine is highly efficacious against chloroquine-resistant Plasmodium vivax malaria and Plasmodium falciparum malaria in Papua, Indonesia.
Maguire JD; Krisin ; Marwoto H; Richie TL; Fryauff DJ; Baird JK
Clin Infect Dis; 2006 Apr; 42(8):1067-72. PubMed ID: 16575721
[TBL] [Abstract][Full Text] [Related]
5. Plasmodium vivax resistance to chloroquine in Madagascar: clinical efficacy and polymorphisms in pvmdr1 and pvcrt-o genes.
Barnadas C; Ratsimbasoa A; Tichit M; Bouchier C; Jahevitra M; Picot S; Ménard D
Antimicrob Agents Chemother; 2008 Dec; 52(12):4233-40. PubMed ID: 18809933
[TBL] [Abstract][Full Text] [Related]
6. Island-wide diversity in single nucleotide polymorphisms of the Plasmodium vivax dihydrofolate reductase and dihydropteroate synthetase genes in Sri Lanka.
Schousboe ML; Rajakaruna RS; Salanti A; Hapuarachchi HC; Galappaththy GN; Bygbjerg IC; Amerasinghe PH; Konradsen F; Alifrangis M
Malar J; 2007 Mar; 6():28. PubMed ID: 17349045
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphism in pvmdr1 and pvcrt-o genes in relation to in vitro drug susceptibility of Plasmodium vivax isolates from malaria-endemic countries.
Lu F; Lim CS; Nam DH; Kim K; Lin K; Kim TS; Lee HW; Chen JH; Wang Y; Sattabongkot J; Han ET
Acta Trop; 2011 Feb; 117(2):69-75. PubMed ID: 20933490
[TBL] [Abstract][Full Text] [Related]
8. Parasitological and clinical efficacy of standard treatment regimens against Plasmodium falciparum, P. vivax and P. malariae in Papua New Guinea.
Genton B; Baea K; Lorry K; Ginny M; Wines B; Alpers MP
P N G Med J; 2005; 48(3-4):141-50. PubMed ID: 17212060
[TBL] [Abstract][Full Text] [Related]
9. The malaria threat.
Croft AM; Geary KG
Med Trop (Mars); 2001; 61(1):63-6. PubMed ID: 11584659
[TBL] [Abstract][Full Text] [Related]
10. Molecular markers of in vivo Plasmodium vivax resistance to amodiaquine plus sulfadoxine-pyrimethamine: mutations in pvdhfr and pvmdr1.
Marfurt J; de Monbrison F; Brega S; Barbollat L; Müller I; Sie A; Goroti M; Reeder JC; Beck HP; Picot S; Genton B
J Infect Dis; 2008 Aug; 198(3):409-17. PubMed ID: 18582193
[TBL] [Abstract][Full Text] [Related]
11. [Importance of a regional observatory of malarial chemoresistance, an emerging public health problem in the Guyanas region].
Esterre P; Volney B; Meynard JB; Legrand E
Bull Soc Pathol Exot; 2009 Aug; 102(3):179-84. PubMed ID: 19739416
[TBL] [Abstract][Full Text] [Related]
12. Identification of the Plasmodium vivax mdr-like gene (pvmdr1) and analysis of single-nucleotide polymorphisms among isolates from different areas of endemicity.
Brega S; Meslin B; de Monbrison F; Severini C; Gradoni L; Udomsangpetch R; Sutanto I; Peyron F; Picot S
J Infect Dis; 2005 Jan; 191(2):272-7. PubMed ID: 15609238
[TBL] [Abstract][Full Text] [Related]
13. Vivax malaria: also a challenge to biomedical sciences and services.
Vaidya AD; Joshi J; Vaidya RA; Godse C; Bhatt R; Bhagwat AN
J Assoc Physicians India; 1999 Dec; 47(12):1220-1. PubMed ID: 11225239
[No Abstract] [Full Text] [Related]
14. Novel mutations in the antifolate drug resistance marker genes among Plasmodium vivax isolates exhibiting severe manifestations.
Garg S; Saxena V; Lumb V; Pakalapati D; Boopathi PA; Subudhi AK; Chowdhury S; Kochar SK; Kochar DK; Sharma YD; Das A
Exp Parasitol; 2012 Dec; 132(4):410-6. PubMed ID: 23043980
[TBL] [Abstract][Full Text] [Related]
15. A cluster of Plasmodium vivax malaria in an expedition group to Ethiopia: prophylactic efficacy of atovaquone/proguanil on liver stages of P. vivax.
Mavrogordato A; Lever AM
J Infect; 2012 Sep; 65(3):269-74. PubMed ID: 22609735
[TBL] [Abstract][Full Text] [Related]
16. Malaria and mefloquine prophylaxis use among Japan Ground Self-Defense Force personnel deployed in East Timor.
Fujii T; Kaku K; Jelinek T; Kimura M
J Travel Med; 2007; 14(4):226-32. PubMed ID: 17617844
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic efficacy of chloroquine in Plasmodium vivax from areas with different epidemiological patterns in India and their Pvdhfr gene mutation pattern.
Valecha N; Joshi H; Eapen A; Ravinderan J; Kumar A; Prajapati SK; Ringwald P
Trans R Soc Trop Med Hyg; 2006 Sep; 100(9):831-7. PubMed ID: 16513151
[TBL] [Abstract][Full Text] [Related]
18. [The proper use of antimalarial drugs currently available].
Bourgeade A; Delmont J
Bull Soc Pathol Exot; 1998; 91(5 Pt 1-2):493-6. PubMed ID: 10078393
[TBL] [Abstract][Full Text] [Related]
19. [Polymorphisms of the pfmdr1 gene in field samples of Plasmodium falciparum and their association with therapeutic response to antimalarial drugs and severe malaria in Colombia].
Montoya P; Tobón A; Blair S; Carmona J; Maestre A
Biomedica; 2007 Jun; 27(2):204-15. PubMed ID: 17713631
[TBL] [Abstract][Full Text] [Related]
20. Sulfadoxine-pyrimethamine plus artesunate compared with chloroquine for the treatment of vivax malaria in areas co-endemic for Plasmodium falciparum and P. vivax: a randomised non-inferiority trial in eastern Afghanistan.
Kolaczinski K; Durrani N; Rahim S; Rowland M
Trans R Soc Trop Med Hyg; 2007 Nov; 101(11):1081-7. PubMed ID: 17707447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
